Stay updated with breaking news from ஷீலா ஃபோர்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Detroit Lions Announce Release Of Long-Time Long Snapper Don Muhlbach | Newsradio WOOD 1300 and 106.9 FM iheart.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iheart.com Daily Mail and Mail on Sunday newspapers.
Nonprofits, investors make effort to revitalize blighted areas of Harrisburg wgal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wgal.com Daily Mail and Mail on Sunday newspapers.
Lions president Rod Wood says Detroit remains in the mix to host future NFL draft Updated Mar 31, 2021; Posted Mar 31, 2021 AP FILE NFL Commissioner Roger Goodell talks about the Walter Payton NFL Man of the Year award during the NFL Honors ceremony as part of Super Bowl 55 in Tampa, Fla., in this Friday, Feb. 5, 2021, file photo. (AP Photo/Charlie Riedel, File)AP Facebook Share ALLEN PARK Detroit could host a future NFL draft, with Lions president Rod Wood saying he hopes the city is a “serious contender” for hosting duties in 2024. Wood spoke to reporters via Zoom after attending the league’s annual meetings with team owner Sheila Ford Hamp. The team’s interest in hosting the draft shouldn’t surprise anyone, with previous attempts to bring one and another Super Bowl to the Motor City. ....
Another local medical provider is offering an intravenous antibody therapy that may help COVID-19 patients avoid hospital stays and recover more quickly with fewer complications. The Wright Center for Community Health is now operating a Scranton outpatient infusion clinic administering the monoclonal antibody bamlanivimab, which received emergency use authorization as a COVID-19 treatment in November. âMonoclonal antibodies are laboratory-made proteins that mimic the immune systemâs ability to fight off harmful pathogens like viruses,â according to the U.S. Food and Drug Administration. Developed by the pharmaceutical firm Eli Lilly and Co., bamlanivimab is a monoclonal antibody specifically directed against the spike protein of SARS-CoV-2, the virus that causes COVID-19. Itâs âdesigned to block the virusâ attachment and entry into human cells,â according to the FDA. ....